Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for…
Continue Reading
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an…
Continue Reading
Terry Ciesla, Senior Vice President at ScribeEMR, explains in this video how various AI scribes can be evaluated on the basis on how well they handle complex, obscure, and subtle details.He offers an example…
Continue Reading
The Mount Sinai Health System on Monday announced its new Center for Artificial Intelligence in Children’s Health, which will explore new ways to develop, test and embed AI directly into pediatric healthcare to enable…
Continue Reading
Large Language Models (LLMs) show promise in healthcare tasks but face challenges in complex medical scenarios. We developed a Multi-Agent Conversation (MAC) framework for disease diagnosis, inspired by clinical Multi-Disciplinary Team discussions. Using 302…
Continue Reading
Rare diseases, affecting ~350 million people worldwide, pose significant challenges in clinical diagnosis due to the lack of experienced physicians and the complexity of differentiating between numerous rare diseases. To address these challenges, we…
Continue Reading
What You Should Know:
– Orsini, a leader in rare disease pharmacy solutions, announced today a new partnership with PicnicHealth, a health technology company dedicated to simplifying observational research.
– This collaboration enables rapid development of drug-specific registries…
Continue Reading
What You Should Know:
– StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that it has acquired Maynard, Mass.-based EmpiraMed Inc., a digital health…
Continue Reading
What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmaceutical companies…
Continue Reading
A Silicon Valley-based startup formerly known as Ciitizen relaunched as Citizen Health on Tuesday — as well as announced a $14.5 million seed funding round led by Transformation Capital and a new partnership with…
Continue Reading
